Pfizer Stock Rises While Broader Markets Fall Ahead of Q2 Earnings Release
• Pfizer (PFE) stock rose 0.26% while broader markets declined • Upcoming Pfizer earnings release will be important with projected 53.66% YoY decline in EPS • Pfizer expected to report revenue decline of 23.44% YoY to $14B • For full year, consensus estimates project Pfizer EPS growth of 20.11% on revenue growth of 2.32% • Pfizer trades at Forward P/E of 12.37, indicating discount vs industry average P/E of 14.44